Skip to main content

Table 2 Mean intensity of JUNB, CXCR4, TYROBP, PRDX1, NFYA, and YWHAB in breast cancer cell lines, PBMCs, and CTCs

From: The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization

Mean intensity

Normal PBMCs

Patients PBMCs

SKBR3

MCF7

MDA-MB 231

Hela

Int CTCs

JUNB

5.2 ± 0.15

4.4 ± 0.11

26.1 ± 1.8

8.9 ± 0.56

6.6 ± 0.15

6.2 ± 0.65

9.6 ± 6.3

CXCR4

10.62 ± 1.01

25.4 ± 1.59

168.8 ± 8.25

13.86 ± 0.51

10.22 ± 0.7

26.85 ± 2.69

33.57 ± 9.25

TYROBP

5.17 ± 0.67

4.82 ± 0.21

3.97 ± 0.13

3.61 ± 0.1

5.08 ± 0.09

3.49 ± 0.24

8.89 ± 3.53

PRDX1

15.9 ± 3.62

34.73 ± 9.69

3.53 ± 0.22

6.25 ± 0.18

22.01 ± 1.64

4.83 ± 0.00

29.34 ± 24.65

NFYA

5.91 ± 0.52

6.08 ± 0.25

3.95 ± 0.23

4.93 ± 0.09

7.26 ± 0.15

5.41 ± 0.18

5.20 ± 1.36

YWHAB

26.13 ± 10.10

0 ± 0

4.04 ± 0.15

7.60 ± 0.12

26.45 ± 3.52

8.20 ± 0.4

5.70 ± 0.28